Rite Aid Corp

Latest Rite Aid Corp News and Updates

  • uploads///RAD_WBA comps
    Miscellaneous

    Could the Rite Aid–Walgreens Merger Get Competitive?

    In the Rite Aid–Walgreens merger, Walgreens is paying about 0.6x trailing-12-month revenues and 13.6x trailing-12-month EBITDA.

    By Brent Nyitray, CFA, MBA
  • uploads///LL Issuance
    Consumer

    Must-know leveraged loan update: Issuance increased last week

    The primary loan market remained busy with opportunistic issuers coming in to test the investor’s interest for floating interest rate loans.

    By Sandra Nathanson
  • uploads///Cumulative Flows in  Year Until November
    Company & Industry Overviews

    High-Yield Bond Mutual Funds: What to Expect in 2016

    If you’re a moderate investor invested in high-yield bond mutual funds, you could consider moving some of your assets to investment grade funds (OPIGX).

    By David Ashworth
  • uploads///
    Earnings Report

    Walgreens’s Deal with Rite Aid Still on, but Delayed

    In October 2015, Walgreens Boots Alliance (WBA) announced its intention to acquire Rite Aid (RAD) for a total enterprise value of $17.2 billion.

    By Sonya Bells
  • uploads///rad pm
    Earnings Report

    Rite Aid’s Revenue Rose and Income Fell in Fiscal 3Q16

    Rite Aid (RAD) has a market cap of $8.2 billion. After the fiscal 3Q16 earnings report, Rite Aid fell by 0.25% to close at $7.88 per share as of December 17, 2015.

    By Gabriel Kane
  • uploads///RAD_WBA market shares
    Miscellaneous

    Can the Walgreens-Rite Aid Merger Get Antitrust Approval?

    The Walgreens-Rite Aid merger is a combination of the first and third largest pharmacies in the United States.

    By Brent Nyitray, CFA, MBA
  • uploads///Part
    Macroeconomic Analysis

    The 6 Positive Things about April’s Retail Sales Report

    The advance retail sales report for April 2015 was on the whole, mixed. The mixed readings in the retail sales report brought about indifferent reactions from markets.

    By Phalguni Soni
  • uploads///
    Miscellaneous

    The WBA-RAD Merger and the 43% Fall in Rite Aid Stock

    Uncertainty over closing the proposed merger between Walgreens Boots Alliance (WBA) and Rite Aid (RAD) has resulted in a 42.8% fall in RAD stock YTD.

    By Sonya Bells
  • uploads///
    Company & Industry Overviews

    CVS versus Walgreens: Which Has a More Diversified Business Model?

    CVS generates close to 70% of its annual sales by offering a full range of pharmacy benefit management services.

    By Sonya Bells
  • uploads///Total IG Bond Issuance in Week Ending May
    Company & Industry Overviews

    Walgreens Boots Alliance Issued the Most High-Grade Bonds

    Walgreens Boots Alliance (WBA) issued Baa2/BBB rated high-grade bonds worth $6.0 billion through five parts on May 26.

    By Lynn Noah
  • uploads///gnc pm
    Earnings Report

    GNC Holdings Reports Mixed 4Q15 Results: Where to This Year?

    GNC Holdings (GNC) has a market cap of $2.2 billion. GNC rose by 1.6% to close at $26.98 per share on February 11, 2016.

    By Gabriel Kane
  • uploads///Part
    Company & Industry Overviews

    Why Target Is Focusing on Its Signature Categories to Drive Sales

    Target has identified four signature categories it’s concentrating on to provide higher store and web traffic and sales: Baby, Style, Wellness, and Kids.

    By Phalguni Soni
  • uploads///
    Company & Industry Overviews

    Amazon Challenges Walgreens and CVS Health Again

    Amazon (AMZN) recently began letting customers use funds in their special healthcare savings account to pay for purchases of eligible products on its marketplace, the company confirmed to CNBC.

    By Ruchi Gupta
  • uploads///
    Consumer

    Walgreens: Key Revenue Drivers in Fourth Quarter of Fiscal 2018

    Walgreens’s Retail Pharmacy USA division accounted for 76% of fourth-quarter sales and increased 14.4% YoY to $25.5 billion.

    By Sonya Bells
  • uploads///
    Consumer

    Strong Q2 2018 Results Cushion CVS Health’s Falling Share Price

    CVS Health’s (CVS) better-than-expected second-quarter results managed to please investors.

    By Sonya Bells
  • uploads///us pharmacies
    Company & Industry Overviews

    How Pharmacies and Drugstores Are Defending against Amazon

    Amazon’s (AMZN) purchase of PillPack is expected to pose a threat to existing players in the pharmaceutical space.

    By Anne Shields
  • uploads///grocery store _
    Consumer

    SuperValu Has Decided to Sell Farm Fresh

    SuperValu (SVU) announced on March 14 that it’s selling 21 of its 38 Farm Fresh stores to three grocery store chains.

    By Sonya Bells
  • uploads///
    Consumer

    How the Drug Store Industry Is Changing

    The top three drugstore chains in the US are in the process of forming new associations through mergers and acquisitions to create a more diversified portfolio and protect themselves from the growing online threat.

    By Sonya Bells
  • uploads///
    Consumer

    Wall Street’s Take on Rite Aid after 3Q17 Results

    Wall Street kept its stance unchanged on Rite Aid (RAD) after its third-quarter results. Evercore ISI, however, initiated coverage on the company on January 5 with an “underperform” rating.

    By Sonya Bells
  • uploads///
    Consumer

    Walgreens Delivers Strong Top-Line Growth in 1Q18

    As we’ve discussed, Walgreens Boots Alliance (WBA) reported its 1Q18 results on January 4. The company’s top line increased 7.9% YoY (year-over-year) to $30.74 billion.

    By Sonya Bells
  • uploads///
    Consumer

    Walgreens Beats 1Q18 Sales and Earnings Expectations

    Walgreens Boots Alliance (WBA) reported its results for 1Q18 on Thursday, January 4. The results relate to the three-month period ending November 30, 2017.

    By Sonya Bells
  • uploads///
    Consumer

    Stock Watch: No Respite for Rite Aid’s Shareholders

    As we discussed throughout this series, Rite Aid (RAD) reported better-than-expected quarterly profits on January 3. However, the third quarter results couldn’t stop the slide in the company’s stock price.

    By Sonya Bells
  • uploads///
    Consumer

    Depressed Retail Pharmacy Gross Profit Impacts Rite Aid’s 3Q17

    Rite Aid Corporation (RAD) reported third-quarter results on January 3. The company’s adjusted net earnings from continuing operations stood at $1.6 million, or $0.00 per diluted share, compared to $26.8 million or $0.03 per diluted share during the same period last year.

    By Sonya Bells
  • uploads///a
    Consumer

    Rite Aid’s Top Line Plunges for the 3rd Straight Quarter in 3Q17

    Rite Aid (RAD) reported its 3Q17 results after the market closed on January 3. The company’s top line plunged 5.6% YoY (year-over-year) to $5.35 billion (excluding discontinued operations).

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid’s 3Q17 Results: A Quick Look

    Rite Aid Corporation (RAD) reported results for 3Q17 on Wednesday, January 3. The results relate to the three-month period ending December 2, 2017.

    By Sonya Bells
  • uploads///a
    Consumer

    Deal of the Year: CVS to Buy Aetna for $69 Billion

    CVS Health (CVS), America’s largest pharmacy chain, announced a $69 billion deal to purchase Aetna (AET), the country’s third-largest insurance company, on December 3, 2017.

    By Sonya Bells
  • uploads///Petmed Risks
    Company & Industry Overviews

    Key Risks Facing PetMed Express in 2017

    PetMed Express (PETS) stock has risen 77% in the last one-year period, reaching a high of $50.06 on July 26, 2017.

    By Kenneth Smith
  • uploads///PetMed Revenue growth
    Company & Industry Overviews

    New Customer Acquisition Drives Revenue Growth for PetMed Express

    In 2017, the PetMed Express (PETS) website attracted ~32.0 million visitors, ~8.0% of whom placed an order for a conversion ratio of ~25.0%.

    By Kenneth Smith
  • uploads///Part
    Company & Industry Overviews

    Analysts’ Recommendations for PetMed Express and Peers in 2017

    Of the five analysts covering PetMed Express (PETS) in October 2017, two gave it “strong buy” ratings, two gave it “hold” ratings, and one gave it a “sell” rating. Its target price was $43.75.

    By Kenneth Smith
  • uploads///
    Consumer

    CVS Health May Vertically Integrate Further by Acquiring Aetna

    With trailing 12-month sales of $181 billion, CVS Health is a pharmacy colossus. However, its focus seems to be on becoming more than just a retail pharmacy chain.

    By Sonya Bells
  • uploads///
    Consumer

    Walgreens: Strong 4Q17 Results Support the Falling Stock Price

    Walgreens Boots Alliance’s strong 4Q17 results were received well by the market. The company’s stock price rose 3% and closed at $69.36 on October 25.

    By Sonya Bells
  • uploads///
    Consumer

    Can Walgreens Exceed Analyst Expectations in Fiscal 4Q17?

    Walgreens Boots Alliance (WBA) is slated to release its fiscal 4Q17 earnings on October 25. WBA’s total sales are expected to reach $29.6 billion, a 4.6% increase over its fiscal 4Q16 sales.

    By Sonya Bells
  • uploads///
    Company & Industry Overviews

    Walgreens versus CVS: Comparing Pharmacy Giants

    The US drugstore market is dominated by two major players—CVS Health (CVS) and Walgreens Boots Alliance (WBA). CVS and WBA accounted for ~29% of the country’s prescription dispensing revenues in 2016.

    By Sonya Bells
  • uploads///
    Consumer

    Walgreens, Rite Aid, CVS Tumble on the Amazon Scare

    Three months after its Whole Foods acquisition, Amazon is making waves again with rumors that it is eying the prescription drug distribution business.

    By Sonya Bells
  • uploads///
    Consumer

    A Look at Rite Aid’s Stock Crash This Year

    Rite Aid’s shareholders have been the real losers from the delay and eventual termination of the deal between Rite Aid (RAD) and Walgreens Boots Alliance (WBA) in October 2015.

    By Sonya Bells
  • uploads///
    Consumer

    Status Update: The Walgreens–Rite Aid Acquisition Deal

    According to Bloomberg, Walgreens Boots Alliance (WBA) and Rite Aid (RAD) have moved toward closing their long-awaited acquisition deal.

    By Sonya Bells
  • uploads///
    Consumer

    Here’s Why Rite Aid’s Margins Have Deteriorated over the Years

    Rite Aid’s profitability has worsened over the years. Its gross margin has fallen from 29.0% in fiscal 2013 to just 22.6% in the first quarter of the current fiscal year.

    By Sonya Bells
  • uploads///
    Consumer

    Rite Aid Ready to Report 2Q17 Earnings: What to Expect

    Rite Aid (RAD) is slated to release its fiscal 2Q17 results on Thursday, September 28, 2017. Its EPS (earnings per share) is projected to fall to zero from last year’s $0.01.

    By Sonya Bells
  • uploads///
    Fund Managers

    Behind Einhorn’s Top Sells in 1Q17

    As of March 31, 2017, the top selling in billionaire investor David Einhorn’s portfolio included Apple, Time Warner, Rite Aid, and AerCap Holdings.

    By Sarah Sands
  • uploads///
    Miscellaneous

    Wall Street Sees a 22% Upside in Walgreens

    Walgreens is covered by 25 Wall Street analysts. The company has received a rating of 2 on a scale of 1 (strong buy) to 5 (sell). It has 72% “buy” and 28% “hold” recommendations and no “sell” recommendations.

    By Sonya Bells
  • uploads///
    Earnings Report

    Walgreens, Rite Aid, and Fred’s: The Shifting Landscape

    WBA’s CEO, Stefano Pessina, said that he remains positive about the Rite Aid deal, which has been waiting for FTC approval for more than a year.

    By Sonya Bells
  • uploads///
    Miscellaneous

    What’s Happened since the Walgreens–Rite Aid October 2015 Deal?

    The merger of Walgreens and Rite Aid would join the second- and third-largest drugstore chains and thus significantly reduce competition.

    By Sonya Bells
  • uploads///
    Miscellaneous

    Who Loses with the Walgreens–Rite Aid Amended Merger Agreement?

    Walgreens Boots Alliance (WBA) and Rite Aid (RAD) have amended their merger agreement. WBA will now pay less for each RAD share, depending on the number of locations it must divest.

    By Sonya Bells
  • uploads///
    Earnings Report

    Walgreens’s Currency Headwinds for Its International Businesses

    In the last couple of quarters, Walgreens Boots Alliance’s (WBA) fiscal 1Q17 top line was negatively affected by currency headwinds, falling 1.8% YoY.

    By Sonya Bells
  • uploads///
    Earnings Report

    Walgreens Boots Alliance’s SWOT Analysis ahead of 1Q17 Results

    Let’s wrap up this series on Walgreens (WBA) with a brief SWOT (strengths, weaknesses, opportunities, and threats) to gauge the company’s standing.

    By Sonya Bells
  • uploads///
    Miscellaneous

    Where Does Walgreens’s Deal with Rite Aid Stand a Year Later?

    Walgreens’s deal with Rite Aid is currently awaiting the Federal Trade Commission’s (or FTC) approval. The FTC has asked Walgreens to close or sell ~650 stores.

    By Sonya Bells
  • uploads///gnc ps
    Earnings Report

    How Does GNC Holdings Compare to Its Peers?

    GNC’s peers have outperformed GNC Holdings based on PE and PBV ratios. But GNC has mostly outperformed its peers based on PS ratios.

    By Gabriel Kane
  • uploads///gnc pm
    Earnings Report

    GNC Holdings’ 3Q16 Revenue Fell 8.1%: What Does It Mean?

    GNC Holdings (GNC) reported 3Q16 revenue of $628.0 million, a fall of 8.1%. Its gross profit margin and operating margin fell 240 bps and 170 bps, respectively.

    By Gabriel Kane
  • uploads///gnc pm
    Consumer

    Analyzing GNC Holdings’ Performance in 2Q16

    GNC Holdings has a market cap of $1.5 billion. It fell by 25.5% and closed at $20.28 per share on July 28, 2016. It reported 2Q16 revenue of $673.2 million.

    By Gabriel Kane
  • uploads///
    Consumer

    How Was Walgreens’s Retail Pharmacy Business Performance in the US?

    Walgreens (WBA) operates close to 8,200 pharmacies in the US. It is closely followed by CVS Health (CVS), which operates slightly fewer than 8,000 pharmacies.

    By Sonya Bells
  • uploads///
    Earnings Report

    What Were the Key Revenue Drivers for WBA in 1Q16?

    Walgreens Boots Alliance’s (WBA) sales rose 48.5% YoY (year-over-year) to $29 billion in 1Q16. The increase was largely driven by the consolidation of Alliance Boots’ operations.

    By Sonya Bells
  • uploads///gnc sm
    Earnings Report

    4Q15: How Did GNC Holdings’ Segments Perform?

    GNC Holdings (GNC) reported revenue of $618.2 million, a rise of 1.8% over the corresponding period last year.

    By Gabriel Kane
  • uploads///
    Company & Industry Overviews

    Looking at Walgreens Boots Alliance’s Strengths and Weaknesses

    In this section, we’ll look at Walgreens Boots Alliance’s (WBA) current strengths and weaknesses.

    By Sonya Bells
  • uploads///
    Company & Industry Overviews

    Upcoming Opportunities and Potential Threats for Walgreens Boots

    In this part, we’ll discuss the company’s upcoming opportunities and potential threats.

    By Sonya Bells
  • uploads///Stock Price Chart
    Company & Industry Overviews

    An Analysis of Walgreens Boots Alliance’s Stock Returns

    Walgreen Boots Alliance’s (WBA) common stock trades on the NASDAQ under the symbol “WBA.”

    By Sonya Bells
  • uploads///
    Company & Industry Overviews

    Comparing the Pharmacy Giants: Walgreens versus CVS Health

    Walgreens Boots Alliance (WBA) and CVS Health (CVS) largely dominate the US drug store market.

    By Sonya Bells
  • uploads///
    Company & Industry Overviews

    An Overview of the US Drugstore Industry

    US drugstores typically generate revenues by selling prescription drugs, over-the-counter medications, health and beauty products, and general merchandise.

    By Sonya Bells
  • uploads///
    Company & Industry Overviews

    A Snapshot of Walgreens Boots Alliance

    Headquartered in Deerfield, Illinois, Walgreens Boots Alliance (WBA) is the second-largest pharmacy retail chain in the United States.

    By Sonya Bells
  • uploads///
    Company & Industry Overviews

    A Breakdown of Walgreens Boots’ Retail Pharmacy USA Division

    Walgreens Boots Alliance’s (WBA) Retail Pharmacy USA division can be broken down into pharmacy and retail components.

    By Sonya Bells
  • uploads///
    Company & Industry Overviews

    A Look at Walgreens Boots Alliance’s Retail Pharmacy USA Division

    The Retail Pharmacy USA division is Walgreens Boots Alliance’s (WBA) largest revenue generator.

    By Sonya Bells
  • uploads///
    Company & Industry Overviews

    Walgreens Boots Alliance’s Retail Pharmacy International Division

    Under its Retail Pharmacy International division, Walgreens Boots Alliance operates pharmacy-led health and beauty retail businesses in eight countries.

    By Sonya Bells
  • uploads///RAD_WBA RAD comps groth
    Miscellaneous

    Parsing the Rite Aid-Walgreens MAE Clause: Part 3

    The MAE (material adverse effect) clause lays out the circumstances under which Walgreens Boots Alliance (WBA) can back out of its merger with Rite Aid (RAD).

    By Brent Nyitray, CFA, MBA
  • uploads///RAD_WBA RAD basics
    Miscellaneous

    Rite Aid-Walgreens Merger: What Does Rite Aid Bring to the Table?

    Rite Aid is the third largest retail drugstore chain in the United States based on both revenues and number of stores.

    By Brent Nyitray, CFA, MBA
  • uploads///RAD_WBA wellness store of the future
    Miscellaneous

    Rationale for the Rite Aid–Walgreens Merger

    The Rite Aid–Walgreens merger is expected to be accretive to Walgreens Boots Alliance’s adjusted earnings per share in the first year after completion.

    By Brent Nyitray, CFA, MBA
  • uploads///part
    Miscellaneous

    Walgreens-Rite Aid Deal: How Would It Impact the Industry?

    The US pharmacy and drugstore industry is worth $263 billion in total sales and $10.3 billion in profit. Walgreens and Rite Aid are ranked second and third.

    By Sonya Bells
  • uploads///part
    Miscellaneous

    Walgreens-Rite Aid Deal: Understanding the Economics

    This is an all-cash deal. It means that Walgreens proposed to buy Rite Aid by paying $9.4 billion in cash. The payment won’t include any stock component.

    By Sonya Bells
  • uploads///part
    Miscellaneous

    Analyzing Walgreens and Rite Aid: 2 Pharmacy Giants

    Walgreens acquired drugstore operator Alliance Boots in December 2014. With the acquisition, Walgreens entered into Europe, the Middle East, and Asia.

    By Sonya Bells
  • uploads///rad pe
    Earnings Report

    How Does Rite Aid’s Performance Compare to Its Peers?

    Rite Aid’s peers outperformed it based on gross profit, diluted EPS, and the PE ratio. The ETFs outperformed it based on the PE ratio and price movement.

    By Gabriel Kane
  • uploads///abdefefcedfedafafe
    Earnings Report

    Why CVS Health’s Stock Fell after Its 2Q15 Earnings Release

    CVS Health’s stock price slumped by 2.5% to $109.96 on August 4, the day the company declared its 2Q15 earnings. CVS’ performance in its higher-margin Retail Pharmacy segment was disappointing.

    By Phalguni Soni
  • uploads///Part
    Earnings Report

    CVS’ Retail Pharmacy Market Share Rises in 2Q15 on Scripts Growth

    CVS Health’s Retail Pharmacy segment reported sales of $17.2 billion in 2Q15, an increase of 2.2% over 2Q14. CVS boosted its share of the retail pharmacy market to 21.6% in 1Q15, from 21% in 2Q14.

    By Phalguni Soni
  • uploads///Part
    Earnings Report

    Key Drivers Affecting CVS’s Profitability in 2015

    CVS Health’s (CVS) profitability is falling. Its gross margins have been on the decline, partly due to a shift in the sales mix in its Pharmacy Services segment.

    By Phalguni Soni
  • uploads///Part
    Earnings Report

    Major Factors Driving CVS’s Retail Pharmacy Segment Growth

    CVS Health (CVS) expects Retail Pharmacy sales growth between 0.5% and 2% year-over-year in 2Q15. Total same-store sales are expected to be in the range of -1.25% to 0.25%.

    By Phalguni Soni
  • uploads///Part
    Miscellaneous

    CVS Goes Shopping: Financing the Target Purchase

    CVS Health has been aggressively expanding, announcing its intention to acquire long-term care provider Omnicare in May for $12.7 billion in an all-cash deal.

    By Phalguni Soni
  • uploads///Part
    Miscellaneous

    Mapping the Store Traffic Attractors in the Target–CVS Deal

    Target’s customer traffic has been pressured in the last two years, partly due to the data breach in 2013. Plus, the number of transactions has been declining.

    By Phalguni Soni
  • uploads///
    Fund Managers

    Fairholme Bulks Up its Position in Sears Holdings

    Eddie Lampert, chairman and CEO of Sears Holdings, has made it clear that he intends to create value through monetizing the company’s real estate assets.

    By Santiago Solari
  • © Copyright 2022 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.